品牌仿制药市场概览、增长、趋势、分析、研究报告(2021-2031 年)

  • Report Code : TIPRE00005554
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Branded Generics Market Overview and Forecast by 2031

Buy Now

品牌仿制药市场规模预计将从 2023 年的 2588.5 亿美元增至 2031 年的 5704 亿美元。预计 2023-2031 年期间该市场的复合年增长率将达到 10.38%。医疗保健提供者和专业人士对品牌仿制药的使用率不断上升,这可能仍是市场的一个主要趋势。

品牌仿制药市场分析

品牌仿制药以品牌名称出售,没有专利。它们可以由仿制药公司或原始制造商开发,并在原始药物的专利到期后上市。提交简化新药申请 (ANDA) 以获得监管部门批准,并且必须在治疗上与原始药物等效。它们的推出有利于品牌公司,因为它们可以利用现有的专业知识生产,不需要单独的 FDA 批准,并且可以在专利到期前推出而没有法律障碍。品牌仿制药在市场上的渗透率不断提高,以及政府推动品牌仿制药发展的举措预计将有利于市场的增长。

品牌仿制药市场概览

各大公司一直在实施各种有机和无机战略,促进了市场的增长。例如,2021 年 4 月,WEX Pharmaceuticals Inc. 宣布在《毒素杂志》的特刊上发表了两项关于河豚毒素 (TTX) 的临床试验。心血管应用的安全性研究“河豚毒素的安全性、耐受性、药代动力学和浓度-QTc 分析:健康成人随机剂量递增研究”被收录在《毒素杂志》特刊中。亚太市场受到中国和印度国际参与者不断增加的投资、政府对中国等国家品牌仿制药发展的支持力度加大、品牌仿制药使用量不断增加以及该地区医疗保健基础设施不断推进的推动。因此,该地区为品牌仿制药市场参与者在预测期内的增长提供了巨大的潜力。

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

品牌仿制药市场:

品牌仿制药市场
  • Branded Generics Market
    复合年增长率(2023 - 2031)
    10.38%
  • 2023 年市场规模
    2588.5 亿美元
  • 2031年市场规模
    5,704亿美元

市场动态

增长动力
  • 由于价格实惠,品牌仿制药受到市场青睐,其采用率不断上升
  • 推动政府推动品牌仿制药的发展,促进市场增长
未来的趋势
  • 医疗保健提供者和专业人员对品牌仿制药的使用
机会
  • 品牌药专利独占权的丧失和生物仿制药的出现带来未来机遇

关键人物;主力;重要一员

  • 异性恋
  • 阿斯彭控股
  • 山德士国际有限公司
  • Par Pharmaceuticals, INC
  • 雷迪博士实验室
  • 阿斯利康公司
  • 赛诺菲
  • 鲁冰花
  • 博士伦保健公司
  • 葛兰素史克公司

区域概况

Branded Generics Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Branded Generics Market治疗应用
  • 肿瘤学
  • 心血管疾病
  • 糖尿病
  • 神经病学
  • 胃肠道疾病
  • 皮肤科疾病
  • 镇痛消炎药
Branded Generics Market药物类别
  • 烷化剂
  • 抗代谢药物
  • 激素
  • 抗高血压
  • 降脂药物
  • 抗抑郁药
  • 抗精神病药物
  • 抗癫痫
Branded Generics Market配方类型
  • 口服
  • 肠外
  • 主题
Branded Generics Market分销渠道
  • 医院
  • 零售药店
  • 网上药店
  • 药店
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

品牌仿制药市场驱动因素和机遇

品牌仿制药渗透率不断上升,市场前景看好

根据 VOXEU 发布的报告,品牌仿制药是其他药物的廉价替代品。由于医疗保健系统节省了成本,并且能够投资未来的新药,因此品牌仿制药在人群中的使用率有所提高。根据国际仿制药和生物类似药协会 (IGBA) 于 2021 年 5 月发布的一份报告,仿制药占全球主要市场所有药品销量的 60-80%,在某些国家甚至更高(例如,美国超过 90%,澳大利亚超过 80%,印度超过 90%,约旦约 85%)。该行业保持具有成本效益的价格的能力,加上规模,使该行业能够在全球范围内显着扩大各种疗法的覆盖范围和可及性。例如,在丙型肝炎仿制抗病毒药物上市一年内,开始接受治疗的人数增加了 50%。因此,扩大仿制药的渗透率是全球品牌仿制药市场份额的主要驱动力。

个性化医疗趋势带来未来机遇

精准医疗通过根据每个人独特的基因组成量身定制治疗方案来推动医疗保健的发展。这种方法也称为个性化医疗或基因组医学,利用遗传学和基因组学为各种健康状况提供更好的疾病预防、更准确的诊断、更安全的药物处方和更有效的治疗。品牌仿制药具有相同的药理作用,而且具有成本效益。品牌仿制药的这些优势使其成为个性化治疗的更好选择。例如,根据 2023 年发表在美国临床药理学和治疗学会 (ASCPT) 上的一篇文章,一项比较仿制药氯吡格雷和其品牌药对治疗急性心肌梗死 (AMI) 患者的有效性的研究发现,仿制药在心血管和出血结果方面与品牌药同样有效。这表明仿制药在个性化治疗中的使用具有积极影响,个性化医疗方法可能会为品牌仿制药市场带来丰厚的机会。

品牌仿制药市场报告细分分析

有助于得出品牌仿制药市场分析的关键部分是治疗应用、药物类别、配方类型和分销渠道。

  • 根据治疗应用,品牌仿制药市场细分为肿瘤科、心血管疾病、胃肠道疾病、糖尿病、神经科、皮肤科疾病、镇痛消炎药等。其他领域在 2023 年占据了最大的市场份额。
  • 根据药物类别,市场细分为抗代谢药物、激素、抗高血压药物、烷化剂、降脂药物、抗抑郁药物、抗精神病药物、抗癫痫药物等。其他药物在 2023 年占据了最大的市场份额。
  • 根据剂型,品牌仿制药市场分为口服、肠外、外用和其他。口服部分在 2023 年占据了最大的市场份额。
  • 就分销渠道而言,市场分为医院、零售药店、网上药店和药店。零售药店在 2023 年占据了相当大的市场份额。

按地区划分的品牌仿制药市场份额分析

品牌仿制药市场报告的地理范围主要分为五个地区:北美、亚太、欧洲、中东和非洲、南美和中美。

北美占据了市场主导地位。仿制药的普及增加了药品支出的份额。根据美国国家医学图书馆 (NLM) 发表的一篇文章,目前美国超过 90% 的药品处方都是以仿制药的形式发放的。根据美国食品药品管理局 (FDA) 2020 年发布的报告,首仿药对公共健康至关重要;2020 年,72 种首仿药获得了 FDA 批准。此外,FDA 估计,品牌仿制药在过去十年中帮助医疗保健系统节省了 2.2 万亿美元。由于该地区品牌仿制药的使用率不断上升,北美在 2023 年占据了最大份额。预计亚太地区未来几年的复合年增长率最高。

品牌仿制药市场报告范围

报告属性细节
2023 年的市场规模2588.5亿美元
2031 年市场规模5704亿美元
全球复合年增长率(2023 - 2031)10.38%
历史数据2021-2022
预测期2024-2031
涵盖的领域按治疗应用
  • 肿瘤学
  • 心血管疾病
  • 糖尿病
  • 神经病学
  • 胃肠道疾病
  • 皮肤科疾病
  • 镇痛消炎药
按药物类别
  • 烷化剂
  • 抗代谢药物
  • 激素
  • 抗高血压
  • 降脂药物
  • 抗抑郁药
  • 抗精神病药物
  • 抗癫痫
按配方类型
  • 口服
  • 肠外
  • 主题
按分销渠道
  • 医院
  • 零售药店
  • 网上药店
  • 药店
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 异性恋
  • 阿斯彭控股
  • 山德士国际有限公司
  • Par Pharmaceuticals, INC
  • 雷迪博士实验室
  • 阿斯利康公司
  • 赛诺菲
  • 鲁冰花
  • 博士伦保健公司
  • 葛兰素史克公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

品牌仿制药市场新闻和最新发展

通过收集主要和次要研究后的定性和定量数据来评估品牌仿制药市场,其中包括重要的公司出版物、协会数据和数据库。以下列出了品牌仿制药市场的一些发展情况:

  • 诺华旗下山德士在美国推出了艾伯维的 Combigan 仿制药,Combigan 是一种用于治疗眼压升高的复方滴眼液。作为最畅销的品牌复方青光眼药物,该药物在 2021 年在美国的销售额达到 3.73 亿美元。随着该药物的推出,该公司正在扩大其眼药产品范围。(来源:山德士,公司网站,2022 年 4 月)
  • GSK 同意以每股 55 美元现金收购 Sierra Oncology,这是一家位于加利福尼亚州的后期生物制药公司,专注于治疗罕见癌症的靶向疗法,总股权价值约为 19 亿美元(15 亿英镑)。(来源:葛兰素史克公司,新闻稿,2022 年 4 月)

品牌仿制药市场报告覆盖范围和交付成果

“品牌仿制药市场规模和预测(2021-2031 年)”报告对市场进行了全面的细分,涵盖了以下领域:

  • 品牌仿制药市场规模以及范围涵盖的所有主要细分市场的全球、区域和国家层面的预测
  • 品牌仿制药市场趋势,以及驱动因素、限制因素和关键机遇等市场动态
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 品牌仿制药市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及品牌仿制药市场的最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region dominated the branded generics market in 2023?

North America dominated the branded generics market in 2023.

What are the driving factors impacting the branded generics market?

Factors such as the rising penetration of branded generics in the market and spurring government initiatives for the development of branded generics are driving the branded generics market growth.

What are the future trends of the branded generics market?

The rising utilization of branded generics by healthcare providers and professionals is a future trend in the market.

Which are the leading players operating in the branded generics market?

Hetero, Aspen Holdings, Sandoz International GMBH, Par Pharmaceuticals, INC, Dr. Reddy's Laboratories, AstraZeneca PLC, Sanofi, Lupin, Bausch Health Companies Inc., GlaxoSmithKline plc., Teva Pharmaceutical Industries Ltd, Mylan N.V are some leading players operating in the branded generics market.

What would be the estimated value of the branded generics market by 2031?

The branded generics market is estimated to reach US$ 934.57 million by 2031.

What is the expected CAGR of the branded generics market?

The branded generics market is anticipated to grow at a CAGR of 11.20% during 2023-2031.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Pharmaceuticals : READ MORE..